Inspire Increases Production of AzaSite in Response to Shortage

Inspire Pharmaceuticals, Inc. announced that it has been communicating with the FDA and is increasing its production of AzaSite (azithromycin ophthalmic solution) 1% in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).
Yahoo! Finance